To promote a better understanding of the issues affecting people with MS and their families, the MS Society prepares and promotes position papers and briefs about key MS igssues. Below are links to recent position papers, briefs to Parliament and Parliamentary committees, patient input submissions related to drug reviews and other documents.
Recently, the Canadian Agency for Drugs and Technologies in Health (CADTH) implemented a process by which organizations representing people affected by various health conditions can provide input into the drug review process relating to public drug plan decision making. The MS Society’s submissions to CADTH’s Common Drug Review are included below.
The Multiple Sclerosis Society works closely with other organizations and with many departments within the federal government to advance issues of importance to people affected by MS. Here are a number of helpful links.
